INS and Insulin resistance: Studies conducted among patients with SCH confirm the lack of impact of levothyroxine treatment on the results of the glucose tolerance test and insulin resistance measured by indirect methods, such as HOMA-IR or quantitative insulin sensitivity check index (QUICKI) [38].